Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,748 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Systemic Therapy and Its Surgical Implications in Patients with Resectable Liver Colorectal Cancer Metastases. A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference.
Ahmed S, Bosma N, Moser M, Ahmed S, Brunet B, Davies J, Doll C, Dueck DA, Kim CA, Ji S, Le D, Lee-Ying R, Lim H, McGhie JP, Mulder K, Park J, Ravi D, Renouf DJ, Schellenberg D, Wong RPW, Zaidi A. Ahmed S, et al. Among authors: moser m. Curr Oncol. 2022 Mar 8;29(3):1796-1807. doi: 10.3390/curroncol29030147. Curr Oncol. 2022. PMID: 35323347 Free PMC article.
Report from the Western Canadian Gastrointestinal Cancer Consensus Conference Virtual Education Series-Transition from Local to System Therapy and Optimal Sequencing of Systemic Therapy for HCC.
Zaidi A, Ahmed S, Ahmed S, Brunet B, Davies J, Doll C, Dueck DA, Gordon V, Hebbard P, Kim C, Le D, Lee-Ying R, Lim H, Liu D, McGhie JP, Mulder K, Park J, Renouf D, Schellenberg D, Wong RPW, Moser M. Zaidi A, et al. Among authors: moser m. Curr Oncol. 2021 Oct 29;28(6):4317-4327. doi: 10.3390/curroncol28060367. Curr Oncol. 2021. PMID: 34898545 Free PMC article.
Early discontinuation of adjuvant chemotherapy in patients with early-stage pancreatic cancer correlates with inferior survival: A multicenter population-based cohort study.
Muhammadzai J, Haider K, Moser M, Chalchal H, Shaw J, Gardiner D, Dueck DA, Ahmed O, Brunet B, Iqbal M, Luo Y, Beck G, Zaidi A, Ahmed S. Muhammadzai J, et al. Among authors: moser m. PLoS One. 2022 Feb 2;17(2):e0263250. doi: 10.1371/journal.pone.0263250. eCollection 2022. PLoS One. 2022. PMID: 35108323 Free PMC article.
Distinct roles but cooperative effect of TLR3/9 agonists and PD-1 blockade in converting the immunotolerant microenvironment of irreversible electroporation-ablated tumors.
Babikr F, Wan J, Xu A, Wu Z, Ahmed S, Freywald A, Chibbar R, Wu Y, Moser M, Groot G, Zhang W, Zhang B, Xiang J. Babikr F, et al. Among authors: moser m. Cell Mol Immunol. 2021 Dec;18(12):2632-2647. doi: 10.1038/s41423-021-00796-4. Epub 2021 Nov 15. Cell Mol Immunol. 2021. PMID: 34782757 Free PMC article.
1,748 results